| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $11.9M | $11.7M | $13.9M |
| YoY Revenue Growth % | +1.8% | -16.2% | — |
| Gross Profit | $4.6M | $4.8M | — |
| Gross Margin % | 38.9% | 41.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.8M | -$2.0M | -$439.0K |
| Operating Margin % | -15.4% | -17.6% | -3.1% |
| Net Income (GAAP) | -$1.6M | -$2.0M | -$383.0K |
| EBITDA (Normalized) | -$1.8M | -$1.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$112.0K | -$367.0K | -$116.0K |
| Capital Expenditures (CapEx) | $56.0K | $177.0K | — |
| Free Cash Flow (FCF) | -$168.0K | -$544.0K | -$116.0K |
| FCF Margin % | -1.4% | -4.7% | -0.8% |
| Return on Invested Capital (ROIC %) | -22.2% | -21.5% | — |
| Cash & Short-Term Equivalents | $2.7M | $3.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $9.2M | $10.5M | — |